In addition, studies have pointed out that genetically-driven NAFLD-related genes such as PNPLA3 and TM6SF2 genes are associated with increased liver fat content and progression to NASH and cirrhosis. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.